Showing posts with label GlaxoSmithKline. Show all posts
Showing posts with label GlaxoSmithKline. Show all posts

Monday, May 18, 2015

Suppression of Clinical Trials of Sumatriptan

Correspondence to the Lancet two weeks ago revealed another instance in which clinical research studies that failed to provide results favor...
Suppression of Clinical Trials of Sumatriptan Rating: 4.5 Diposkan Oleh: Unknown

Sunday, May 17, 2015

More Evidence for Suppression of Research: the Case of Lamictal for Depression

We recently discussed the severe challenges to evidence-based medicine presented by manipulation and suppression of clinical research to ...
More Evidence for Suppression of Research: the Case of Lamictal for Depression Rating: 4.5 Diposkan Oleh: Unknown

Wednesday, May 13, 2015

Bring Back the DSI*? - the Avandia Case as Spy Novel

Starting in 2007, we posted quite a bit about the "Avandia case," which centered on whether Avandia (rosiglitazone, by GlaxoSmithK...
Bring Back the DSI*? - the Avandia Case as Spy Novel Rating: 4.5 Diposkan Oleh: Unknown

Tuesday, May 12, 2015

Quis Custodiet Ipsos Custodes?

HAPPY TIMES AT NIMH Two weeks ago I discussed a Commentary in JAMA by Dr. Thomas Insel, Director of the National Institute of Mental Heal...
Quis Custodiet Ipsos Custodes? Rating: 4.5 Diposkan Oleh: Unknown

Thursday, May 7, 2015

The Avandia Spin Cycle Continues Even After the FDA Safety Hearings

We have posted multiple times about Avandia (rosiglitazone), GlaxoSmithKline's star-crossed glucose-lowering drug.  While Avandia has re...
The Avandia Spin Cycle Continues Even After the FDA Safety Hearings Rating: 4.5 Diposkan Oleh: Unknown

Friday, August 21, 2009

Another Haunting Tale

Halloween is more than two months away, but the ghost stories just keep on coming. The latest version was reported by the Associated Press ...
Another Haunting Tale Rating: 4.5 Diposkan Oleh: Unknown

Wednesday, August 19, 2009

High Costs and Poor Outcomes - A Lesson About the Suppression of Research

Last week, blogger Alison Bass was one of the few to comment on a new article on the risks of antidepressant medications published electron...
High Costs and Poor Outcomes - A Lesson About the Suppression of Research Rating: 4.5 Diposkan Oleh: Unknown